Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. - Wikidata - wikimedia - TriplyDB

Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.

Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.

http://www.wikidata.org/entity/Q34372135

about

The epigenetic landscape of addiction Epigenetic mechanisms in drug addiction Current status and future prospects for epigenetic psychopharmacology Histone regulation in the CNS: basic principles of epigenetic plasticity Increased histone H3 phosphorylation in neurons in specific brain structures after induction of status epilepticus in mice Drug-induced epigenetic changes produce drug tolerance A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS)Maternal separation alters drug intake patterns in adulthood in rats.Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors The Brain-Specific Neural Zinc Finger Transcription Factor 2b (NZF-2b/7ZFMyt1) Suppresses Cocaine Self-Administration in Rats.Phospho-acetylation of histone H3 in the amygdala after acute lithium chloride.Genomic analysis of individual differences in ethanol drinking: evidence for non-genetic factors in C57BL/6 mice.Potential molecular and cellular mechanism of psychotropic drugs The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases.Histone deacetylase inhibitors decrease reelin promoter methylation in vitro.Epigenetic mechanisms in schizophrenia.Lack or inhibition of dopaminergic stimulation induces a development increase of striatal tyrosine hydroxylase-positive interneurons Epigenetic signaling in schizophrenia Epigenetic mechanisms of memory formation and reconsolidation.Histone Posttranslational Modifications in Schizophrenia.Chromatin regulation in drug addiction and depression.A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling.Horizons of psychiatric genetics and epigenetics: where are we and where are we heading?Haloperidol regulates the state of phosphorylation of ribosomal protein S6 via activation of PKA and phosphorylation of DARPP-32 Whole genome methylation analyses of schizophrenia patients before and after treatment.Repetitive transcranial magnetic stimulation induces long-lasting changes in protein expression and histone acetylation Epigenetics in the human brain Isolation of neuronal chromatin from brain tissue The future of neuroepigenetics in the human brain.Decoding the epigenetic language of neuronal plasticity.How the epigenome contributes to the development of psychiatric disorders.Epigenetic regulation of gene expression in physiological and pathological brain processes.Signaling from the cytoplasm to the nucleus in striatal medium-sized spiny neurons Epigenetics of psychoactive drugs.Matters of life and death: the role of chromatin remodeling proteins in retinal neuron survival Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.Epigenetic developmental programs and adipogenesis: implications for psychotropic induced obesity.Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back.

P2860

Q24624411-89E2A43D-03DB-4C78-8C03-D87D0DE8AF07 Q24645709-6EC492C3-A3E2-436C-93AD-DEC38A04D672 Q26825464-6953AE51-3844-4844-B0D9-6922B3E6CCB5 Q26829142-8BB6D93B-465F-40FE-A15A-5A60932CF496 Q27303742-516DF821-C089-46B3-8879-85CDC8C009EA Q28469326-697B7853-0A52-40E3-BFC0-E951D40DE567 Q28535325-2161A462-C579-4741-97D7-1A77F6CE3827 Q28652508-1DCFE877-A4F1-4BFF-9203-7F99A1BABEC7 Q30489086-4152ABC1-76FF-4FDE-ABE3-24E648D6BA60 Q30490304-23F0BDFD-8088-4344-AF8E-FEA7719F8002 Q33788985-662A2F78-74E1-4A96-BA75-5C4E0211E50E Q33857133-32B0C825-8AD1-4C8A-9308-C1CE7FD25685 Q33940849-A1837AC6-0FB2-4A2B-9DCF-7F7093680218 Q34129880-B25AD6EB-542D-4573-9B09-27B4FBDDC217 Q34334999-8844AF48-D168-48B9-9CFC-344DB48D20A7 Q34409611-11FBD3F2-DC67-464C-B862-96CFA2AE2C0B Q34426222-2BAA65CB-5780-423C-8E46-7A2F72FF4E62 Q34426902-11EAA844-0600-4853-84C4-8AF25B3C96F4 Q34482708-640B23C5-F425-4C32-929D-F9BF4E215D28 Q34602482-CB190889-6553-4F06-B17C-34BC69743B28 Q34682060-D587A05B-6B82-451E-9DD6-4B523A5D88A6 Q35010534-24DBA5C9-D2D7-4DB8-AE51-CE9766C8F815 Q35024117-AFD7BB5C-FDA6-45C9-BBD0-9E3B3657F252 Q35106605-18EBF2D2-0B4B-4F10-AF5F-9BBB8183B719 Q35177686-B62D8F98-C265-4FC0-9B65-1E2CAD241FB5 Q35356825-B9508044-6537-4CE6-95C1-F8126A20DE20 Q35614046-57817926-826A-41C0-8E2A-881372836504 Q36301103-826BFACF-49A4-4E5A-9F6D-6BB8125BEB08 Q36465858-2F51133F-B40C-417C-8E34-902CC5C5BABD Q36649298-B5A05D62-CA51-46CB-8EEA-33065B1C78AF Q36891239-CD8CE2DC-7092-406B-999A-277D6E19B4CE Q37358580-0C0946BA-B32B-4C1B-9F72-0C3C1510CAA5 Q37686429-C501F4F4-04D2-498A-8524-29FAC40C5294 Q37870034-B699C783-CE1D-4A46-8696-FDA2149D4220 Q37903674-E7162E25-8B44-4629-8E4A-647F1C311AF7 Q38040133-EA13C79C-A3C3-4B2A-8CD8-F782CFCA6144 Q38071621-237AEF06-E282-4EB0-9DF6-20C050FB8689 Q38079160-7199D976-5241-4037-9E55-EF5432454609 Q38130106-FB70C669-95C8-4E2A-B61E-97C54FEAB572 Q38262765-019ECCB1-EC24-4BBA-80EE-1404B002285A

P2860

Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.

http://www.wikidata.org/entity/Q34372135

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Dopamine D2-like antagonists i ...... A and NMDA receptor signaling.

@ast

Dopamine D2-like antagonists i ...... A and NMDA receptor signaling.

@en

Dopamine D2-like antagonists i ...... A and NMDA receptor signaling.

@nl

type

label

Dopamine D2-like antagonists i ...... A and NMDA receptor signaling.

@ast

Dopamine D2-like antagonists i ...... A and NMDA receptor signaling.

@en

Dopamine D2-like antagonists i ...... A and NMDA receptor signaling.

@nl

prefLabel

Dopamine D2-like antagonists i ...... A and NMDA receptor signaling.

@ast

Dopamine D2-like antagonists i ...... A and NMDA receptor signaling.

@en

Dopamine D2-like antagonists i ...... A and NMDA receptor signaling.

@nl

P1433

Q34372135-2092EEB9-15E5-4988-B3F0-7D246F876F0C

P1476

Q34372135-78E7B52C-EEE1-468C-AFF5-7B2FE9BBECA9

P2093

Q34372135-00B55816-3FC1-4AB8-B6AD-2DDA4B5AB742

Q34372135-0F053EE0-F202-4B06-887D-38841D4A6B4A

Q34372135-30FB91A2-2EAA-4F9B-9417-1D9702251A1D

Q34372135-4A6BC445-19AB-480A-9257-F31CEACA4453

Q34372135-CB65E0D9-0C90-4AF7-BF58-C8A07F6D4EDF

Q34372135-D302B323-411E-4615-963E-3210928A3C56

Q34372135-E40DE086-4842-427D-9A51-C459A1A2E4FC

Q34372135-F20E2D11-0105-4088-AB0A-2CC160CE1C93

P2860

Q34372135-014DB30A-7DBC-4D57-87B8-996E2130A784

Q34372135-015E6E50-86E3-43C1-8F08-A90BC01D1699

Q34372135-06418688-E12E-4E80-8DD1-F5C6FC8A5B79

Q34372135-06F28711-C5A6-4909-AA69-C93DEEBA2068

Q34372135-0C205FBD-D873-4CA9-96F7-4C6224A055E8

Q34372135-0C541E10-EF4C-436D-9272-7CF7BE1AEC34

Q34372135-1053E968-1722-4B71-BBD4-D1762C9476C7

Q34372135-10A05BD6-28A3-44AF-A61E-6D754A2E631F

Q34372135-132EB051-86C2-4C4A-A956-9B5EBAF225A0

Q34372135-1728D05A-B16A-4F67-A3B2-0FB586617413

P304

Q34372135-4CB1080F-C2BC-4B40-BB2A-10D31565CA80

P31

Q34372135-0FFFB3BB-8A48-43B2-ADE0-0D774D70EE07

P356

Q34372135-182456EF-3D8F-460E-B8B4-95C2EAD28DD0

P407

Q34372135-C7D1BA19-1B90-43A3-B34A-41499AEDC8BD

P433

Q34372135-68217781-3ADD-49EF-8F53-698166B135E2

P478

Q34372135-4CC21254-9FC8-440D-B190-96A1938BA01D

P577

Q34372135-8E92D1F5-795F-45C3-82AB-453E7188516D

P5875

Q34372135-4D09E9DA-47EF-4450-A2CD-A9914505F16E

P698

Q34372135-9938955C-E927-4CF5-85A9-77D2DAEA41D9

P921

Q34372135-89866417-C806-46A7-A06D-5CE10A5A8A61

Q34372135-cf40236b-7a7e-498d-8ef3-3493fde22674

P932

Q34372135-F8BC5177-93FF-4815-B98B-74734283E8C0

P356

J.1471-4159.2004.02569.X

P1433

Journal of Neurochemistry

P1476

Dopamine D2-like antagonists i ...... A and NMDA receptor signaling.

@en

P2093

Christine Konradi

http://www.w3.org/2001/XMLSchema#string

Craig Ferris

http://www.w3.org/2001/XMLSchema#string

Frederick A Schroeder

http://www.w3.org/2001/XMLSchema#string

Jianhong Li

http://www.w3.org/2001/XMLSchema#string

Rachael M Youngs

http://www.w3.org/2001/XMLSchema#string

Schahram Akbarian

http://www.w3.org/2001/XMLSchema#string

Thomas W Schmidt

http://www.w3.org/2001/XMLSchema#string

Yin Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons

Translating the Histone Code

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission

Dopamine receptors: from structure to function

Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum

Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice

Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia

Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation

Looping and interaction between hypersensitive sites in the active beta-globin locus

Cellular memory and the histone code

P304

1117-1131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1471-4159.2004.02569.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8399581

http://www.w3.org/2001/XMLSchema#string

P698

15312167

http://www.w3.org/2001/XMLSchema#string

P921

corpus striatum

P932

4203323

http://www.w3.org/2001/XMLSchema#string